Radiopharm Theranostics Statistics

Total Valuation

RADX has a market cap or net worth of $36.10 million. The enterprise value is $11.85 million.

Market Cap	36.10M
Enterprise Value	11.85M

Important Dates

The last earnings date was Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

RADX has 2.20 billion shares outstanding. The number of shares has increased by 243.78% in one year.

Current Share Class	n/a
Shares Outstanding	2.20B
Shares Change (YoY)	+243.78%
Shares Change (QoQ)	+327.30%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.51B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	176.43
Forward PS	n/a
PB Ratio	1.12
P/TBV Ratio	11.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	57.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.37

Current Ratio	3.37
Quick Ratio	3.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-59.53

Financial Efficiency

Return on equity (ROE) is -112.21% and return on invested capital (ROIC) is -59.05%.

Return on Equity (ROE)	-112.21%
Return on Assets (ROA)	-28.95%
Return on Invested Capital (ROIC)	-59.05%
Return on Capital Employed (ROCE)	-45.48%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, RADX has paid $102,799 in taxes.

Income Tax	102,799
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.80
52-Week Price Change	n/a
50-Day Moving Average	4.49
200-Day Moving Average	n/a
Relative Strength Index (RSI)	58.73
Average Volume (20 Days)	16,680

Short Selling Information

The latest short interest is 24,964, so 0.00% of the outstanding shares have been sold short.

Short Interest	24,964
Short Previous Month	49,824
Short % of Shares Out	0.00%
Short % of Float	0.00%
Short Ratio (days to cover)	0.81

Income Statement

In the last 12 months, RADX had revenue of $204,609 and -$26.61 million in losses. Loss per share was -$0.02.

Revenue	204,609
Gross Profit	-13.23M
Operating Income	-22.32M
Pretax Income	n/a
Net Income	-26.61M
EBITDA	-20.42M
EBIT	-22.32M
Loss Per Share	-$0.02

Full Income Statement

Balance Sheet

The company has $22.55 million in cash and n/a in debt, giving a net cash position of $22.55 million or $0.01 per share.

Cash & Cash Equivalents	22.55M
Total Debt	n/a
Net Cash	22.55M
Net Cash Per Share	$0.01
Equity (Book Value)	32.18M
Book Value Per Share	0.01
Working Capital	19.31M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.68M
Capital Expenditures	n/a
Free Cash Flow	-21.46M
FCF Per Share	-$0.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-10,908.65%
Pretax Margin	-12,905.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RADX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-243.78%
Shareholder Yield	-243.78%
Earnings Yield	-73.72%
FCF Yield	-59.44%

Analyst Forecast

The average price target for RADX is $13.50, which is 181.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.50
Price Target Difference	181.84%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	134.88%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RADX has an Altman Z-Score of -2.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.23
Piotroski F-Score	2